legislation: 106-hr-5467
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106-hr-5467 | 106 | hr | 5467 | Breast Cancer Prescription Drug Fairness Act | Health | 2000-10-12 | 2000-10-25 | Referred to the Subcommittee on Health and Environment. | House | Rep. McCarthy, Carolyn [D-NY-4] | NY | D | M000309 | 0 | Breast Cancer Prescription Drug Fairness Act - Requires each participating manufacturer of a covered outpatient drug to make available for purchase by each pharmacy a covered outpatient drug: (1) in an amount equal to the aggregate amount of the covered outpatient drug sold or distributed by the pharmacy to Medicare beneficiaries (including the amount sold or distributed to Medicare beneficiaries in a hospice program); and (2) at a price equal to the lower of either the lowest price paid for the drug by the Federal Government or the manufacturer's best price for the drug. | 2025-08-20T14:18:31Z |